Bispecific T-cell engager therapy for gastrointestinal cancers.
Saved in:
| Title: | Bispecific T-cell engager therapy for gastrointestinal cancers. |
|---|---|
| Authors: | Burton KA; Department of Medicine, University of Wisconsin, Madison, WI, USA., Metropulos AE; Indiana University School of Medicine, Gary, IN, USA., Kamath SD; Department of Medicine, Division of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Munshi HG; Department of Medicine, Division of Hematology and Oncology, Northwestern University, Chicago, IL, USA; The Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA; Jesse Brown VA Medical Center, Chicago, IL, USA., Principe DR; Department of Medicine, Division of Hematology and Oncology, Northwestern University, Chicago, IL, USA; The Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA. Electronic address: daniel.principe@northwestern.edu. |
| Source: | Cancer letters [Cancer Lett] 2026 May 28; Vol. 646, pp. 218417. Date of Electronic Publication: 2026 Mar 09. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
